评估前列腺放疗中水凝胶直肠间隔物放置充分性的质量指标及其评分与直肠毒性结局的关联
本研究基于42例接受水凝胶直肠间隔物(HSP)联合前列腺立体定向体部放疗(SBRT,45 Gy分5次)的多机构2期研究患者,开发了基于MRI轴位T2加权模拟定位图像的前列腺-直肠间隙测量质量指标(间隔物质量评分SQS),并评估其与直肠剂量学和晚期直肠毒性的关联。SQS与直肠Dmax、D1cc、V45、V40及晚期直肠毒性发生率和最高分级均相关。
要点
- SQS基于直肠中线及旁开±1 cm共9个位点的前列腺-直肠间隙测量计算,间隙<0.3 cm、0.3-0.9 cm、≥1 cm分别计0、1、2分。
- SQS与直肠Dmax(P=0.002)、D1cc(P=0.004)、V45(P=0.046)和V40(P=0.005)相关。
- SQS为0或1分的患者较2分者发生晚期直肠毒性的比值比分别为4.67倍(95%CI 0.72-30.11)和8.40倍(95%CI 1.83-38.57)。
核心结论
- 作者开发了一个可靠且信息丰富的指标用于评估水凝胶直肠间隔物放置,该指标似乎与前列腺SBRT后的直肠剂量学和晚期直肠毒性相关。
研究设计与样本
- 多机构2期研究中使用水凝胶直肠间隔物联合前列腺SBRT(45 Gy分5次)的42例男性患者。
- 基于MRI轴位T2加权模拟定位图像的前列腺-直肠间隙测量构建质量指标,并分析其与直肠剂量学和晚期毒性的关联。
主要发现
- 分析队列中SQS为1分者17例(41%),SQS为2分者18例(43%)。
- SQS与直肠Dmax(P=0.002)、D1cc(P=0.004)、V45(P=0.046)和V40(P=0.005)相关。
- SQS与晚期直肠毒性发生率(P=0.01)和最高分级(P=0.01)相关。
- 20例发生晚期≥1级直肠毒性患者中,SQS为0、1、2分者分别占57%、71%、22%。
- SQS为0分者较2分者晚期直肠毒性OR为4.67(95%CI 0.72-30.11),SQS为1分者较2分者OR为8.40(95%CI 1.83-38.57)。
关键数值与推荐
- 前列腺-直肠间隙测量<0.3 cm计0分,0.3-0.9 cm计1分,≥1 cm计2分。
- SQS由直肠中线及旁开±1 cm共9个位点的个体评分计算,位点位于前列腺基底、中部和尖部。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although hydrogel spacer placement (HSP) minimizes rectal dose during prostate cancer radiation therapy, its potential benefit for modulating rectal toxicity could depend on the achieved prostate-rectal separation. We therefore developed a quality metric associated with rectal dose reduction and late rectal toxicity among patients treated with prostate stereotactic body radiation therapy (SBRT). METHODS AND MATERIALS: A quality metric consisting of prostate-rectal interspace measurements from axial T2-weighted magnetic resonance imaging simulation images was applied to 42 men enrolled in a multi-institutional phase 2 study using HSP with prostate SBRT (45 Gy in 5 fractions). A score of 0, 1, or 2 was assigned to a prostate-rectal interspace measurement of <0.3 cm, 0.3 to 0.9 cm, or ≥1 cm, respectively. An overall spacer quality score (SQS) was computed from individual scores at rectal midline and ±1 cm laterally, located at the prostate base, midgland, and apex. Associations of SQS with rectal dosimetry and late toxicity were evaluated. RESULTS: The majority of the analyzed cohort had an SQS of 1 (n = 17; 41%) or 2 (n = 18; 43%). SQS was associated with maximum rectal point dose (rectal Dmax; P = .002), maximum dose to 1 cc of rectum (D1cc; P = .004), and volume of rectum receiving ≥100% of prescription dose (V45; P = .046) and ≥40 Gy (V40; P = .005). SQS was also associated with a higher incidence of (P = .01) and highest-graded late rectal toxicity (P = .01). Among the 20 men who developed late grade ≥1 rectal toxicity, 57%, 71%, and 22% had an SQS of 0, 1, and 2, respectively. Men with an SQS of 0 or 1 compared with 2 had 4.67-fold (95% CI, 0.72-30.11) or 8.40-fold (95% CI, 1.83-38.57) greater odds, respectively, of developing late rectal toxicity. CONCLUSIONS: We developed a reliable and informative metric for assessing HSP, which appears to be associated with rectal dosimetry and late rectal toxicity after prostate SBRT.
引用
- Grossman CE, Folkert MR, Lobaugh S, et al. Quality Metric to Assess Adequacy of Hydrogel Rectal Spacer Placement for Prostate Radiation Therapy and Association of Metric Score With Rectal Toxicity Outcomes. Adv Radiat Oncol. 2023. PMID: 37213478. doi:10.1016/j.adro.2022.101070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。